Patents Assigned to Eragen Biosciences, Inc.
  • Patent number: 8217160
    Abstract: Solid support assays using non-standard bases are described. A capture oligonucleotide comprising a molecular recognition sequence is attached to a solid support and hybridized with a target. In some instances, the molecular recognition sequence includes one or more non-standard bases and hybridizes to a complementary tagging sequence of the target oligonucleotide. In other instances, incorporation of a non-standard base (e.g., via PCR or ligation) is used in the assay.
    Type: Grant
    Filed: July 20, 2006
    Date of Patent: July 10, 2012
    Assignee: Eragen Biosciences, Inc.
    Inventors: Jennifer K. Grenier, David J. Marshall, James R. Prudent, Craig S. Richmond, Eric B. Roesch, Christopher W. Scherrer, Christopher B. Sherrill, Jerod L. Ptacin
  • Patent number: 7892796
    Abstract: Solid support assays using non-standard bases are described. A capture oligonucleotide comprising a molecular recognition sequence is attached to a solid support and hybridized with a target oligonucleotide. In some instances, the molecular recognition sequence includes one or more non-standard bases and hybridizes to a complementary tagging sequence of the target oligonucleotide. In other instances, incorporation of a non-standard base (e.g., via PCR or ligation) is used in the assay.
    Type: Grant
    Filed: November 19, 2005
    Date of Patent: February 22, 2011
    Assignee: EraGen Biosciences, Inc.
    Inventors: James Prudent, David Marshall, Christopher Sherrill, Eric Roesch, Craig Richmond, Christopher Scherrer, Jennifer Grenier, Jerod Ptacin
  • Patent number: 7820808
    Abstract: The present invention provides nucleic acid based polymerase inhibitors and methods for reducing non-specific polymerase extension and amplification in nucleic acid amplification reactions. The polymerase inhibitors provide a double stranded nucleic acid portion that is recognized by a polymerase enzyme as a template for extension but is incapable of being extended by the polymerase enzyme. The polymerase binds to the polymerase inhibitor which sequesters the enzyme until the temperature achieves a level that denatures the double stranded portion of the inhibitor after which the polymerase is released and can then catalyze nucleic acid extension.
    Type: Grant
    Filed: April 1, 2004
    Date of Patent: October 26, 2010
    Assignee: EraGen Biosciences, Inc.
    Inventors: Michael James Moser, David J. Marshall, James R. Prudent, Christopher V. Van Hout, Christine A. Larsen
  • Patent number: 7741471
    Abstract: The present invention provides the combination of the O-2 diphenylcarbamoyl (“DPC”) and N-6 dimethylaminomethylidene (“DMF”) protecting groups for isoguanosine nucleosides that can be utilized in oligonucleotide synthesis.
    Type: Grant
    Filed: May 26, 2005
    Date of Patent: June 22, 2010
    Assignee: EraGen Biosciences, Inc.
    Inventors: James R. Prudent, Christopher B. Sherrill
  • Patent number: 7541147
    Abstract: Assays using non-natural bases are described. In one embodiment, the method involves contacting a sample suspected of containing the target nucleic acid with a polymerase and first and second primers; amplifying the target nucleic acid, if present in the sample, by PCR using the first and second primers to generate an amplification product having a double-stranded region and a single-stranded region that comprises the non-natural base; contacting the sample with a reporter comprising a label and a non-natural base that is complementary to the non-natural base of the single-stranded region; annealing at least a portion of the reporter to the single-stranded region of the amplification product; and correlating a signal of the label with the presence of the target nucleic acid in the sample. The invention also provides corresponding kits for use in detecting target nucleic acids in a sample.
    Type: Grant
    Filed: October 12, 2006
    Date of Patent: June 2, 2009
    Assignee: EraGen Biosciences, Inc.
    Inventors: David J. Marshall, James R. Prudent, Christopher B. Sherrill, Gideon Shapiro, Simona Jurczyk, Jerod L. Ptacin
  • Patent number: 7517651
    Abstract: Assays using non-natural bases are described. In one embodiment, the method involves contacting a sample suspected of containing the target nucleic acid with a polymerase and first and second primers; amplifying the target nucleic acid, if present in the sample, by PCR using the first and second primers to generate an amplification product having a double-stranded region and a single-stranded region that comprises the non-natural base; contacting the sample with a reporter comprising a label and a non-natural base that is complementary to the non-natural base of the single-stranded region; annealing at least a portion of the reporter to the single-stranded region of the amplification product; and correlating a signal of the label with the presence of the target nucleic acid in the sample. The invention also provides corresponding kits for use in detecting target nucleic acids in a sample.
    Type: Grant
    Filed: July 14, 2006
    Date of Patent: April 14, 2009
    Assignee: EraGen Biosciences, Inc.
    Inventors: David J. Marshall, James R. Prudent, Christopher B. Sherrill, Gideon Shapiro, Simon Jurczyk, Jerod L. Ptacin
  • Patent number: 7514212
    Abstract: The present invention provides methods, kits and compositions for high fidelity nucleic acid amplification reactions of target nucleic acids such that specific amplification products that incorporate non-standard bases are produced. The amplification reactions can either be linear or exponential. In some embodiments, the fidelity of the amplification reaction is high enough such that a majority of the amplification products maintain non-standard bases at specific sites designated by the user after a specified number of amplification cycles. In some embodiments, the ratio of non-standard nucleoside triphosphates is greater than the amount of standard nucleoside triphosphates initially present in the reaction mixture.
    Type: Grant
    Filed: January 17, 2004
    Date of Patent: April 7, 2009
    Assignee: EraGen Biosciences, Inc.
    Inventors: James R. Prudent, Scott C. Johnson, Michael J. Moser, David J. Marshall
  • Patent number: 7498136
    Abstract: Disclosed are methods, kits, and other components for detecting multiple nucleic acids in a sample. The methods and kits may be useful for detecting Neisseria in a sample. In some embodiments, the methods include (a) reacting a mixture that includes (i) nucleic acid isolated from the sample; (ii) at least a first specific primer capable of being used to amplify specifically nucleic acid of Neisseria gonorrhea; (iii) at least a second specific primer capable of being used to amplify specifically nucleic acid of a non-gonococcal species of Neisseria; (iv) at least a universal primer capable of being used to amplify specifically nucleic acid of Neisseria gonorrhea and nucleic acid of a non-gonococcal species of Neisseria; and (b) amplifying and detecting nucleic acid of at least one of Neisseria gonorrhea and a non-gonococcal species of Neisseria. The disclosed kits may include one or more components for performing the disclosed methods.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: March 3, 2009
    Assignee: EraGen Biosciences, Inc.
    Inventor: Scott C. Johnson
  • Patent number: 7422850
    Abstract: Assays using non-natural bases are described. In one embodiment, the method involves contacting a sample suspected of containing the target nucleic acid with a polymerase and first and second primers; amplifying the target nucleic acid, if present in the sample, by PCR using the first and second primers to generate an amplification product having a double-stranded region and a single-stranded region that comprises the non-natural base; contacting the sample with a reporter comprising a label and a non-natural base that is complementary to the non-natural base of the single-stranded region; annealing at least a portion of the reporter to the single-stranded region of the amplification product; cleaving, after annealing, at least a portion of the reporter to release at least one reporter fragment; and correlating the release of the at least one reporter fragment with the presence of the target nucleic acid in the sample.
    Type: Grant
    Filed: May 18, 2001
    Date of Patent: September 9, 2008
    Assignee: Eragen Biosciences, Inc.
    Inventors: David J. Marshall, James R. Prudent, Christopher B. Sherrill, Gideon Shapiro, Jennifer K. Grenier, Craig S. Richmond, Simona Jurczyk, Jerod L. Ptacin
  • Publication number: 20070105099
    Abstract: The present invention provides methods, kits and compositions for high fidelity nucleic acid amplification reactions of target nucleic acids such that specific amplification products that incorporate non-standard bases are produced. The amplification reactions can either be linear or exponential. In some embodiments, the fidelity of the amplification reaction is high enough such that a majority of the amplification products maintain non-standard bases at specific sites designated by the user after a specified number of amplification cycles. In some embodiments, the ratio of non-standard nucleoside triphosphates is greater than the amount of standard nucleoside triphosphates initially present in the reaction mixture.
    Type: Application
    Filed: January 17, 2004
    Publication date: May 10, 2007
    Applicant: EraGen Biosciences, Inc.
    Inventors: James Prudent, Scott Johnson, Michael Moser, David Marshall
  • Patent number: 6977161
    Abstract: Solid support assays using non-standard bases are described. A capture oligonucleotide comprising a molecular recognition sequence is attached to a solid support and hybridized with a target oligonucleotide. In some instances, the molecular recognition sequence includes one or more non-standard bases and hybridizes to a complementary tagging sequence of the target oligonucleotide. In other instances, incorporation of a non-standard base (e.g., via PCR or ligation) is used in the assay.
    Type: Grant
    Filed: October 15, 2001
    Date of Patent: December 20, 2005
    Assignee: Eragen Biosciences, Inc.
    Inventors: Jennifer K. Grenier, David J. Marshall, James R. Prudent, Craig S. Richmond, Eric B. Roesch, Christopher W. Scherrer, Christopher B. Sherrill, Jerod L. Ptacin
  • Patent number: 6941317
    Abstract: A computer research tool is provided for searching and displaying biological data. Specifically, the invention provides a computer research tool for performing computerized research of biological data from various databases and for providing a novel graphical user interface that significantly enhances biological data representation, progressive querying and cross-navigation of windows and databases. The invention can be implemented in numerous ways, including as a system, a device, a method, or a computer readable medium.
    Type: Grant
    Filed: September 14, 1999
    Date of Patent: September 6, 2005
    Assignee: Eragen Biosciences, Inc.
    Inventors: Stephen Chamberlin, Steven A. Benner, Lukas Knecht
  • Publication number: 20040106108
    Abstract: Solid support assays using non-standard bases are described. A capture oligonucleotide comprising a molecular recognition sequence is attached to a solid support and hybridized with a target oligonucleotide the solid support. In some instances, the molecular recognition sequence includes one or more non-standard bases and hybridizes to a complementary tagging sequence of the target oligonucleotide. In other instances, incorporation of a non-standard base (e.g., via PCR or ligation) is used in the assay.
    Type: Application
    Filed: October 15, 2001
    Publication date: June 3, 2004
    Applicant: EraGen Biosciences, Inc.
    Inventors: Jennifer K. Grenier, David J. Marshall, James R. Prudent, Craig S. Richmond, Eric B. Roesch, Christopher W. Scherrer, Christopher B. Sherrill, Jerod L. Ptacin